Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock

Journal of the American Society of Nephrology

Volumn 16, Issue 1, 2005, Pages 117-124

  Boffa, Jean Jacques ^a,b   Arendshorst, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; HYPERTENSIVE AGENT; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN; VASOPRESSIN; ARGIPRESSIN; ENZYME INHIBITOR; NITRIC OXIDE; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTOXEMIA; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SHOCK; STATISTICAL ANALYSIS; VASOCONSTRICTION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; KIDNEY CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SEPTIC SHOCK; URINE;

ANGIOTENSIN II; ANIMALS; ARGININE VASOPRESSIN; ENZYME INHIBITORS; GLOMERULAR FILTRATION RATE; KIDNEY FAILURE, ACUTE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; RENAL CIRCULATION; SHOCK, SEPTIC; URINE; VASOCONSTRICTOR AGENTS;

EID: 21644467801     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004060441     Document Type: Article

References (49)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554, 2003
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001
3. Neveu H, Kleinknecht D, Brivet F, Loirat P, Landais P: Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol Dial Transplant 11: 293-299, 1996
4. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996
5. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B; CUB-Rea Network: Current epidemiology of septic shock: The CUB-Rea Network. Am J Respir Crit Care Med 168: 165-172, 2003
6. Pleiner J, Mittermayer F, Schaller G, Marsik C, MacAllister RJ, Wolzt M: Inflammation-induced vasoconstrictor hyporeactivity is caused by oxidative stress. J Am Coll Cardiol 42: 1656-1662, 2003
7. Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P: The role of inducible nitric oxide synthase in lipopolysaccharide-mediated hyporeactivity to vasoconstrictors differs among isolated rat arteries. Clin Sci (Lond) 102: 297-305, 2002
8. Piepot HA, Boer C, Groeneveld AB, Van Lambalgen AA, Sipkema P: Lipopolysaccharide impairs endothelial nitric oxide synthesis in rat renal arteries. Kidney Int 57: 2502-2510, 2000
9. Farmer MR, Roberts RE, Gardiner SM, Ralevic V: Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta. J Pharmacol Exp Ther 306: 538-545, 2003
10. Li S, Fan SX, McKenna T: Role of nitric oxide in sepsis-induced hyporeactivity in isolated rat lungs. Shock 5: 122-129, 1996
11. Wylam ME, Metkus AP, Umans JG: Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta. Life Sci 69: 455-467, 2001
12. Landry DW, Oliver JA: The pathogenesis of vasodilatory shock. N Engl J Med 345: 588-595, 2001
13. Chen SJ, Wu CC, Yang SN, Lin CI, Yen MH: Hyperpolarization contributes to vascular hyporeactivity in rats with lipopolysaccharide-induced endotoxic shock. Life Sci 68: 659-668, 2000
14. Hwang D: Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J 15: 2556-2564, 2001
15. Vincent JL, Zhang H, Szabo C, Preiser JC: Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 161: 1781-1785, 2000
16. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 351: 159-169, 2004
17. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230-1251, 1999
18. Churchill PC, Bidani AK, Schwartz MM: Renal effects of endotoxin in the male rat. Am J Physiol (Lond) 253: F244-F250, 1987
19. Boffa J-J, Just A, Coffman TM, Arendshorst WJ: Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 15: 2358-2365, 2004
20. Lugon JR, Boim MA, Ramos OL, Ajzen H, Schor N: Renal function and glomerular hemodynamics in male endotoxemic rats. Kidney Int 36: 570-575, 1989
21. van Lambalgen AA, Bouriquet N, Casellas D: Effects of endotoxin on tone and pressure-responsiveness of preglomerular juxtamedullary vessels. Pflugers Arch 432: 574-577, 1996
22. Mitaka C, Hirata Y, Yokoyama K, Nagura T, Tsunoda Y, Amaha K: Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist. Crit Care Med 27: 146-153, 1999
23. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW: Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59: 2243-2249, 2001
24. Schwieger IM, Schiffer ER, Morel DR: Effects of fenoldopam on systemic and splanchnic haemodynamics and oxygen delivery/consumption relationship during hyperdynamic ovine endotoxaemia. Intensive Care Med 24: 509-518, 1998
25. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A: Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775, 2003
26. Pleiner J, Heere-Ress E, Langenberger H, Sieder AE, Bayerle-Eder M, Mittermayer F, Fuchsjager-Mayrl G, Bohm J, Jansen B, Wolzt M: Adrenoceptor hyporeactivity is responsible for Escherichia coli endotoxin-induced acute vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 22: 95-100, 2002
27. Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P: Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res 110: 413-418, 2003
28. Bucher M, Kees F, Taeger K, Kurtz A: Cytokines downregulate α1-adrenergic receptor expression during endotoxemia. Crit Care Med 31: 566-571, 2003
29. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D: Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 97: 9753-9758, 2000
30. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873, 2004
31. Lorenz JN, Gruenstein E: A simple, nonradioactive method for evaluating single-nephron filtration rate using FITC-inulin. Am J Physiol (Lond) 276: F172-F177, 1999
32. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ: Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 101: 296-301, 2004
33. Waller J, Gardiner SM, Bennett T: Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br J Pharmacol 112: 1057-1064, 1994
34. da Silva-Santos JE, Terluk MR, Assreuy J: Differential involvement of guanylate cyclase and potassium channels in nitric oxide-induced hyporesponsiveness to phenylephrine in endotoxemic rats. Shock 17: 70-76, 2002
35. Gardiner SM, Kemp PA, March JE, Bennett T: Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 116: 2005-2016, 1995
36. Wallis G, Brackett D, Lerner M, Kotake Y, Bolli R, McCay PB: In vivo spin trapping of nitric oxide generated in the small intestine, liver, and kidney during the development of endotoxemia: A time-course study. Shock 6: 274-278, 1996
37. Kozlov AV, Szalay L, Umar F, Fink B, Kropik K, Nohl H, Redl H, Bahrami S: Epr analysis reveals three tissues responding to endotoxin by increased formation of reactive oxygen and nitrogen species. Free Radic Biol Med 34: 1555-1562, 2003
38. Rudichenko VM, Beierwaltes WH: Arginine vasopressin-induced renal vasodilation mediated by nitric oxide. J Vasc Res 32: 100-105, 1995
39. Holmes CL, Landry DW, Granton JT: Science Review: Vasopressin and the cardiovascular system part 2-Clinical physiology. Crit Care 8: 15-23, 2004
40. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95: 1122-1125, 1997
41. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 359: 1209-1210, 2002
42. Guzman JA, Rosado AE, Kruse JA: Vasopressin vs norepinephrine in endotoxic shock: Systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol 95: 803-809, 2003
43. Levy B, Vallee C, Lauzier F, Plante G, Mansard A, Mallie JP, Lesur O: Comparative effects of vasopressin, norepinephrine and L-Canavanine, a selective inhibitor of inducible nitric oxide synthase in endotoxic shock. Am J Physiol Heart Circ Physiol 287: H209-H215, 2004
44. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96: 576-582, 2002
45. Bellomo R, Giantomasso DD: Noradrenaline and the kidney: Friends or foes? Crit Care 5: 294-298, 2001
46. Wray GM, Millar CG, Hinds CJ, Thiemermann C: Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin. Shock 9: 329-335, 1998
47. Cheng X, Leung SW, Lo LS, Pang CC: Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia. Naunyn Schmiedebergs Arch Pharmacol 367: 372-379, 2003
48. Shenoy SK, Lefkowitz RJ: Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375: 503-515, 2003
49. Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, Seidman CE, Seidman JG: β-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ Res 81: 1021-1026, 1997